Low Back Myofascitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Over 18 years of age; 2. Persistent chronic low back pain for at least 3 months and met the clinical diagnostic criteria of MPS; 3. Failure of conservative treatment (physical therapy, drug therapy, etc.) 4. Patients voluntarily signed informed consent and were able to complete the questionnaire.
Exclusion criteria
Exclusion criteria: 1. Patients aged under 18 years; 2. Patients with a history of thoracolumbar trauma, or those having undergone thoracolumbar surgery within 3 months prior to enrollment; 3. Patients whose low back pain was confirmed by imaging and clinical examinations to be secondary to other pathologies, including but not limited to thoracolumbar deformity, cervical spondylosis, cardiovascular diseases, mediastinal lesions, thoracic tuberculosis or neoplasms, intraspinal lesions, and abdominal visceral disorders; 4. Pregnant or lactating women, patients with psychiatric disorders, or those with failure of vital organs including the heart, liver, kidney, and hematopoietic system; 5. Patients with contraindications to teasing needle therapy, such as coagulation dysfunction and infection at the puncture site; 6. Patients with known hypersensitivity to study-related medications, including lidocaine, celecoxib, and other non-steroidal anti-inflammatory drugs (NSAIDs); 7. Patients with poor treatment compliance, inability to complete the treatment and follow-up as required by the study protocol, or a high risk of dropout or loss to follow-up during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oswestry Disability Index;Pittsburgh Sleep Quality Index;36-Item Short-Form Health Survey;Clinical treatment effectiveness rate; | — |
Countries
China
Contacts
Shanghai East Hospital, School of Medicine, Tongji University